Soumahoro L, Abitbol V, Vicic N, Bekkat-Berkani R, Safadi M
Infect Dis Ther. 2021; 10(4):1949-1988.
PMID: 34379309
PMC: 8572905.
DOI: 10.1007/s40121-021-00499-3.
Sudbury E, OSullivan S, Lister D, Varghese D, Satharasinghe K
Emerg Infect Dis. 2020; 26(7):1355-1363.
PMID: 32568047
PMC: 7323526.
DOI: 10.3201/eid2607.181941.
Coldiron M, Assao B, Page A, Hitchings M, Alcoba G, Ciglenecki I
PLoS Med. 2018; 15(6):e1002593.
PMID: 29944651
PMC: 6019097.
DOI: 10.1371/journal.pmed.1002593.
Brynildsrud O, Eldholm V, Bohlin J, Uadiale K, Obaro S, Caugant D
Proc Natl Acad Sci U S A. 2018; 115(21):5510-5515.
PMID: 29735685
PMC: 6003489.
DOI: 10.1073/pnas.1802298115.
Meyer S, Novak R
Lancet Infect Dis. 2017; 17(8):789-790.
PMID: 28545720
PMC: 5740483.
DOI: 10.1016/S1473-3099(17)30300-6.
Case-Fatality Rates and Sequelae Resulting from Neisseria meningitidis Serogroup C Epidemic, Niger, 2015.
Coldiron M, Salou H, Sidikou F, Goumbi K, Djibo A, Lechevalier P
Emerg Infect Dis. 2016; 22(10):1827-9.
PMID: 27649257
PMC: 5038434.
DOI: 10.3201/eid2210.160731.
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
Sidikou F, Zaneidou M, Alkassoum I, Schwartz S, Issaka B, Obama R
Lancet Infect Dis. 2016; 16(11):1288-1294.
PMID: 27567107
PMC: 5737706.
DOI: 10.1016/S1473-3099(16)30253-5.
Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria.
Uadiale K, Bestman A, Kamau C, Caugant D, Greig J
Trans R Soc Trop Med Hyg. 2016; 110(7):381-5.
PMID: 27496511
PMC: 4975174.
DOI: 10.1093/trstmh/trw046.
Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.
Cibrelus L, Medah I, Koussoube D, Yelbeogo D, Fernandez K, Lingani C
Emerg Infect Dis. 2015; 21(11):2063-6.
PMID: 26488128
PMC: 4622241.
DOI: 10.3201/eid2111.150304.
Identification of the serotypes of bacterial meningitis agents; implication for vaccine usage.
Attarpour-Yazdi M, Ghamarian A, Mousaviehzadeh M, Davoudi N
Iran J Microbiol. 2015; 6(4):211-8.
PMID: 25802702
PMC: 4367935.
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
Kristiansen P, Ky Ba A, Ouedraogo A, Sanou I, Ouedraogo R, Sangare L
BMC Infect Dis. 2014; 14:663.
PMID: 25472422
PMC: 4267149.
DOI: 10.1186/s12879-014-0663-4.
Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.
Ky Ba A, Sanou I, Kristiansen P, Sangare L, Ouedraogo R, Ouattara K
BMC Infect Dis. 2014; 14:546.
PMID: 25311771
PMC: 4201702.
DOI: 10.1186/s12879-014-0546-8.
Neisseria meningitidis serogroup W, Burkina Faso, 2012.
MacNeil J, Medah I, Koussoube D, Novak R, Cohn A, Diomande F
Emerg Infect Dis. 2014; 20(3):394-9.
PMID: 24571805
PMC: 3944835.
DOI: 10.3201/eid2003.131407.
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
Collard J, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha M
BMC Infect Dis. 2013; 13:576.
PMID: 24313998
PMC: 4029580.
DOI: 10.1186/1471-2334-13-576.
Serogroup W135 meningococcal disease, The Gambia, 2012.
Hossain M, Roca A, Mackenzie G, Jasseh M, Hossain M, Muhammad S
Emerg Infect Dis. 2013; 19(9):1507-10.
PMID: 23965435
PMC: 3810914.
DOI: 10.3201/eid1909.130077.
Spread of Neisseria meningitidis serogroup W clone, China.
Zhou H, Liu W, Xu L, Deng L, Deng Q, Zhuo J
Emerg Infect Dis. 2013; 19(9):1496-9.
PMID: 23965378
PMC: 3810921.
DOI: 10.3201/eid1909.130160.
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
Kristiansen P, Ky Ba A, Sanou I, Ouedraogo A, Ouedraogo R, Sangare L
BMC Infect Dis. 2013; 13:363.
PMID: 23914778
PMC: 3750508.
DOI: 10.1186/1471-2334-13-363.
Meningococcal vaccines: current issues and future strategies.
Cohn A, Harrison L
Drugs. 2013; 73(11):1147-55.
PMID: 23839656
DOI: 10.1007/s40265-013-0079-2.
Knowledge, attitudes, and practices related to meningitis in northern Ghana.
Hayden M, Dalaba M, Awine T, Akweongo P, Nyaaba G, Anaseba D
Am J Trop Med Hyg. 2013; 89(2):265-70.
PMID: 23775016
PMC: 3741247.
DOI: 10.4269/ajtmh.12-0515.
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
Caugant D, Kristiansen P, Wang X, Mayer L, Taha M, Ouedraogo R
PLoS One. 2012; 7(9):e46019.
PMID: 23029368
PMC: 3459830.
DOI: 10.1371/journal.pone.0046019.